Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats

Carlos Martínez-Salgado1, Nélida Eleno, Ana I Morales

  • 1Departamento de Fisiología y Farmacología, Instituto Reina Sofía de Investigación Nefrológica, Universidad de Salamanca, Salamanca, Spain.

Abstract

Insights

Gentamicin induces both proliferation and apoptosis in kidney mesangial cells, potentially mediated by reactive oxygen species (ROS). This balance may preserve normal cell numbers following gentamicin-induced kidney damage.

Area of Science:

  • Nephrology
  • Cell Biology
  • Toxicology

Background:

  • Gentamicin-induced acute renal failure impairs glomerular function without structural changes.
  • Gentamicin stimulates reactive oxygen species (ROS)-mediated mesangial cell proliferation in vitro.
  • The study investigates if gentamicin promotes mesangial cell apoptosis in vitro and if apoptosis and proliferation occur in vivo.

Purpose of the Study:

  • To determine if gentamicin (G) induces apoptosis in mesangial cells in vitro.
  • To investigate the in vivo occurrence of mesangial cell apoptosis and proliferation following gentamicin treatment.
  • To explore the role of reactive oxygen species (ROS) in gentamicin-induced mesangial cell apoptosis.

Main Methods:

  • In vivo studies involved daily gentamicin injections in rats for 6 days, followed by functional and histological assessments.
  • In vitro studies evaluated mesangial cell proliferation and apoptosis after 24, 48, and 72 hours of gentamicin incubation.
  • Assays included DNA synthesis, cell counting, and analysis of apoptotic and survival protein expression (Bax, Bcl-2).

Main Results:

  • Gentamicin treatment in vivo increased proliferating and apoptotic cell numbers without altering the nuclei count per glomerulus.
  • In vitro, gentamicin increased mesangial cell DNA synthesis, cell number, and significantly elevated apoptosis.
  • Reactive oxygen species (ROS) scavengers reduced gentamicin-induced apoptosis, while ROS donors increased it, indicating ROS mediation.

Conclusions:

  • Gentamicin induces simultaneous proliferation and apoptosis of mesangial cells both in vitro and in vivo.
  • Reactive oxygen species (ROS) likely mediate gentamicin-induced mesangial cell apoptosis.
  • The balance between proliferation and apoptosis may maintain normal mesangial cell numbers after gentamicin-induced glomerular injury.